Universal Beteiligungs und Servicegesellschaft mbH Trims Holdings in Astera Labs, Inc. $ALAB

Key Points

• Universal Beteiligungs trimmed its stake in Astera Labs by 55.3% in Q4, selling 51,687 shares and finishing the quarter with 41,716 shares worth about $6.94 million.
• Astera Labs beat Q4 estimates with $0.58 EPS vs. $0.51 expected and revenue of $270.6M (up 91.8% YoY), and set Q1 2026 guidance of $0.530–$0.540 EPS.
• Insiders sold 1,064,888 shares (~$150.8M) last quarter (many under Rule 10b5‑1 plans), while analysts show a consensus "Moderate Buy" with a $199.74 price target; the stock trades at a $33.68B market cap and a P/E of 161.18.

Universal Beteiligungs und Servicegesellschaft mbH trimmed its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 55.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,716 shares of the company's stock after selling 51,687 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH's holdings in Astera Labs were worth $6,941,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nordea Investment Management AB purchased a new stake in Astera Labs during the 4th quarter valued at approximately $2,028,000. Geneva Partners LLC bought a new position in shares of Astera Labs during the 3rd quarter valued at approximately $1,876,000. Numerai GP LLC boosted its position in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company's stock valued at $2,587,000 after acquiring an additional 7,992 shares during the last quarter. Handelsbanken Fonder AB lifted its position in Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company's stock worth $24,710,000 after buying an additional 93,800 shares during the last quarter. Finally, Corient Private Wealth LLC bought a new stake in Astera Labs in the second quarter worth $543,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

Shares of ALAB stock opened at $196.64 on Tuesday. The company has a market cap of $33.68 billion, a price-to-earnings ratio of 161.18, a PEG ratio of 4.19 and a beta of 1.78. The stock has a 50 day simple moving average of $135.22 and a 200-day simple moving average of $152.95. Astera Labs, Inc. has a 1-year low of $62.31 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business's quarterly revenue was up 91.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts anticipate that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ALAB shares. Loop Capital started coverage on Astera Labs in a research note on Thursday, March 5th. They issued a "buy" rating and a $250.00 target price on the stock. Citigroup assumed coverage on Astera Labs in a research note on Thursday, April 2nd. They set a "buy" rating and a $200.00 price target on the stock. Weiss Ratings lowered Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, February 23rd. Barclays set a $165.00 price target on Astera Labs in a research note on Thursday, January 15th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $250.00 price target on shares of Astera Labs in a research note on Tuesday, April 21st. Fifteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $199.74.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares in the company, valued at approximately $12,725,912.68. This represents a 7.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director directly owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,064,888 shares of company stock worth $150,764,723. Insiders own 12.50% of the company's stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.